Sunday, May 28, 2017

LATEST NEWS

Blockchain has been widely slated as the next potential big disruptive technology in the “fintech” space. While blockchain was first proposed by the pseudonymous...

What happens after the ALJ issues his Initial Determination in the Cisco v. Arista ITC investigation? The US International Trade Commission (ITC) is growing popular...
PCSK9 Inhibitors

Amgen’s Repatha and Sanofi/Regeneron’s Praluent are competing for market share in the new class of PCSK9 inhibitors for high-risk cholesterol patients after both were...
1,648FollowersFollow

POPULAR ARTICLES

Forward Pharma’s (FWP) story is an interesting one. A recent IPO, Forward’s main assets are intellectual property and development prospects surrounding treatments for multiple...

When “patent trolls” want to blame a corporate bully for any of their travails, Google is often among the first companies mentioned. There is...

The question of who owns intellectual property rights is always an interesting one. When it comes to professors or engineers at public or private...

LATEST POSTS

Investors have been watching the IPR exploits of Kyle Bass & Co. – and we have discussed the potential investing catalysts created by Bass...

RECENT COMMENTS